Matches in Wikidata for { <http://www.wikidata.org/entity/Q66399013> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q66399013 description "clinical trial" @default.
- Q66399013 description "ensayu clínicu" @default.
- Q66399013 description "klinisch onderzoek" @default.
- Q66399013 description "клінічне випробування" @default.
- Q66399013 description "կլինիկական փորձարկում" @default.
- Q66399013 name "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 name "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 type Item @default.
- Q66399013 label "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 label "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 prefLabel "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 prefLabel "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma" @default.
- Q66399013 P1050 Q66399013-36A8F7FA-E9D7-4060-B102-BDA4487A506B @default.
- Q66399013 P1050 Q66399013-4193F84F-AD62-4620-B68B-3A1C3F365CC6 @default.
- Q66399013 P1132 Q66399013-1299BB63-2386-4A3D-B61E-69202A6BFC1C @default.
- Q66399013 P1476 Q66399013-0BE2C3C8-FE46-48DE-BAEA-2C5E1A4B88B2 @default.
- Q66399013 P17 Q66399013-868BAB1A-701C-4D31-BCB2-8A1A0F6FDFDE @default.
- Q66399013 P2899 Q66399013-9CA68452-06E1-449E-9683-1AC008CB939C @default.
- Q66399013 P3098 Q66399013-7BCD1667-0C24-4736-A283-AA26A58C911F @default.
- Q66399013 P31 Q66399013-674FB164-377F-4A94-A695-AAB382017C89 @default.
- Q66399013 P580 Q66399013-4BC74587-DEB9-4F94-9316-0CD90D271E7C @default.
- Q66399013 P582 Q66399013-7CCE02B4-F74F-4A14-B623-DC61DEF5FE08 @default.
- Q66399013 P6099 Q66399013-C6C126A5-C8EA-4477-8154-1F960169A551 @default.
- Q66399013 P8363 Q66399013-8652A40E-7BEA-4BAC-9663-03ED9C5C2D2E @default.
- Q66399013 P1050 Q1418735 @default.
- Q66399013 P1050 Q7098796 @default.
- Q66399013 P1132 "+24" @default.
- Q66399013 P1476 "Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults With Neurofibromatosis Type 1 (NF1) and Cutaneous Neurofibromas (CNF)" @default.
- Q66399013 P17 Q30 @default.
- Q66399013 P2899 "+18" @default.
- Q66399013 P3098 "NCT02839720" @default.
- Q66399013 P31 Q30612 @default.
- Q66399013 P580 "2017-04-11T00:00:00Z" @default.
- Q66399013 P582 "2021-12-31T00:00:00Z" @default.
- Q66399013 P6099 Q42824440 @default.
- Q66399013 P8363 Q78089383 @default.